FLUORESCENT PCR AND AUTOMATED FRAGMENT ANALYSIS FOR THE CLINICAL-APPLICATION OF PREIMPLANTATION GENETIC DIAGNOSIS OF MYOTONIC-DYSTROPHY (STEINERTS-DISEASE)
K. Sermon et al., FLUORESCENT PCR AND AUTOMATED FRAGMENT ANALYSIS FOR THE CLINICAL-APPLICATION OF PREIMPLANTATION GENETIC DIAGNOSIS OF MYOTONIC-DYSTROPHY (STEINERTS-DISEASE), Molecular human reproduction (Print), 4(8), 1998, pp. 791-796
Myotonic dystrophy (DM), or Steinert's disease, is an autosomal domina
nt disease characterized by myotonia, muscular weakness and atrophy, a
s well as lens opacities, cardiomyopathy and mild endocrine changes. T
he gene for DM located on 19q contains a triplet repeat at the 3' end
of the gene. In DM patients, this repeat is found to be expanded. We h
ave previously described a preimplantation genetic diagnosis (PGD) for
DM using polymerase chain reaction (PCR) followed by conventional ana
lysis on ethidium bromide-stained gels. The major drawback of this sys
tem was that allelic dropout occurred in >20% of the cells, leading to
the loss of healthy embryos for transfer. To resolve this problem, we
developed a PGD for DM using fluorescent PCR followed by fragment ana
lysis on an automated DNA sequencer and made a comparison between the
conventional PCR described earlier and fluorescent PCR, which turned o
ut to be superior in accuracy and efficiency. Three PGD cycles were pe
rformed using fluorescent PCR and are described here.